Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


The Effects of Sedatives on Tobacco Use Disorder Version 2


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT05505630

Organisation Name: Wake Forest University Health Sciences

Overal Status: Not yet recruiting

Start Date: January 3, 2023

Last Update: August 22, 2022

Lead Sponsor: Wake Forest University Health Sciences

Brief Summary: Double-blind, placebo-controlled, randomized mechanistic clinical trial to test a single intravenous dose of ketamine or an active control (midazolam) on cigarette smoking behavior, craving, and neural effects.

Conditions:
  • Tobacco Smoking


Total execution time in seconds: 0.47712898254395